1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Austria Pharmaceuticals and Healthcare Report Q2 2016

Austria Pharmaceuticals and Healthcare Report Q2 2016

  • February 2016
  • -
  • Business Monitor International
  • -
  • 65 pages

Includes 3 FREE quarterly updates


BMI View:
While we view the Austrian pharmaceutical and healthcare market as relatively stable and insulated from sudden downgrades, we highlight that certain economic factors pose a risk to public spending in particular. However, the country's economy is poised to grow in 2016 and therefore, we believe pharmaceutical spending will post modest growth over the medium term, as the government links growth in public healthcare expenditure with nominal GDP growth.


Headline Expenditure Projections
- Pharmaceuticals: EUR6.44bn (USD7.08bn) in 2015 to EUR6.55bn (USD7.01bn) in 2016; 1.7% in local currency terms and -1.1% in US dollar terms. Forecasts in USD terms slightly increased from the previous quarter.
- Healthcare: EUR37.33bn (USD41.06bn) in 2015 to EUR38.75bn (USD41.46bn) in 2016; +3.8% in local currency terms and 1.0% in US dollar terms. Forecasts unchanged from the previous quarter.

Table Of Contents

Austria Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View ... 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Austria 2014-2020) . 7
SWOT 9
Industry Forecast .. 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Austria 2012-2020) . 12
Healthcare Market Forecast .. 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2012-2020) . . 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2012-2020) 16
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Austria 2012-2020) . . 18
Patented Drug Market Forecast . 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Austria 2012-2020) 20
Generic Drug Market Forecast .. 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Austria 2012-2020) . 23
OTC Medicine Market Forecast . 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Austria 2012-2020) . . 25
Pharmaceutical Trade Forecast . 26
Table: Pharmaceutical Trade Data And Forecasts (Austria 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Austria 2014-2020) . . 27
Industry Risk/Reward Index . 28
Western Europe Risk/Reward Index 28
Austria Risk/Reward Index 33
Rewards ... 33
Risks 33
Regulatory Review 35
Intellectual Property Issues .. 37
Pricing Regime .. 37
Reimbursement Regime ... 38
Market Overview ... 40
Healthcare Sector .. 41
Table: Healthcare Resources (Austria 2010-2015) . . 42
Table: Healthcare Personnel (Austria 2010-2015) . . 42
Table: Healthcare Activity (Austria 2010-2015) . 43
Research And Development .. 43
Clinical Trials ... 44
Competitive Landscape 47
Research-Based Industry . 47
Table: Multinational Market Activity . 48
Pharmaceutical Distribution 49
Table: Members Of ARGE Pharmazeutika, 2011 50
Pharmaceutical Retail Sector ... 51
Table: Pharmacy Outlets by Type, 2005-2009 52
Table: Pharmacy Outlets by State, 2005-2009 53
Demographic Forecast . 54
Table: Population Headline Indicators (Austria 1990-2025) 55
Table: Key Population Ratios (Austria 1990-2025) . 55
Table: Urban/Rural Population and Life Expectancy (Austria 1990-2025) . . 56
Table: Population By Age Group (Austria 1990-2025) 56
Table: Population By Age Group % (Austria 1990-2025) . 57
Glossary . 59
Methodology .. 61
Pharmaceutical Expenditure Forecast Model .. 61
Healthcare Expenditure Forecast Model . 61
Notes On Methodology 62
Risk/Reward Index Methodology ... 63
Index Overview .. 64
Table: Pharmaceutical Risk/Reward Index Indicators . 64
Indicator Weightings .. 65

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.